Bristol Laboratories Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the batches in the table for Rabeprazole sodium 10mg and 20mg gastro-resistant tablets do not contain the most up to date safet…
Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - General Practice